Back

Causal AI substantially improves the validity of estimating cardiovascular risk and benefit.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: HOT LINE SESSION 6 Cardiovascular Risk Assessment ESC Professional Premium Access ESC Congress 2022

ESC TV

About the speaker

Photo
Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
eBRAVE-AF - Smartphone-based AF screening.
Professor A. Bauer (Innsbruck, AT)
Slides Video
Presentation thumbnail
Discussant review - eBRAVE-AF .
Doctor E. Svennberg (Stockholm, SE)
Slides Video
Presentation thumbnail
Panel discussion - eBRAVE-AF.
Video
Presentation thumbnail
Discussant review - Causal AI substantially improves the validity of estimating cardiovascular risk and benefit.
Professor F. Asselbergs (Amsterdam, NL)
Slides Video
Presentation thumbnail
Panel discussion - Causal AI substantially improves the validity of estimating cardiovascular risk and benefit.
Video

Access the full session

Session thumbnail
HOT LINE SESSION 6
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Lifetime risk in preventive treatment decisions: the clinical impact of using different prediction horizons to identify individuals at high risk of cardiovascular disease
thumbnail
Congress Presentation
Predicting cardiovascular risk: new horizons - discussion
thumbnail
Congress Presentation
Impact of early atherosclerosis imaging on risk stratification, treatment strategy, and potential clinical outcomes in a primary prevention cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources